Ruthenium complexes as potent antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) via membrane damage
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Wen-Ping Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Ruthenium, Coordination Complexes. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Jiangxi Science and Technology Normal University, Jiangxi Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
With the growing crisis of multidrug-resistant bacterial infections, a series of novel ruthenium complexes were rationally designed and synthesized to disrupt the integrity of bacterial membranes. In vitro antibacterial screening demonstrated that the lead compound Ru-6 possesses potent bactericidal activity against multiple methicillin-resistant Staphylococcus aureus (MRSA) isolates, with minimum inhibitory concentrations (MICs) ranging from 1.56 to 6.25 μg/mL. Concurrently, Ru-6 displayed negligible hemolytic toxicity toward rabbit erythrocytes. Mechanistic studies suggest that Ru-6 exerts its antibacterial effects through a dual-pathway mechanism: phosphatidylglycerol (PG) acts as a potential membrane interaction partner for Ru-6, facilitating bacterial membrane damage; and also Ru-6 treatment triggers elevated reactive oxygen species (ROS) levels, which is speculated to mediate subsequent intracellular injury. Transcriptomic analysis further revealed that Ru-6 modulates the regulation of bacterial internal genes. In vivo experiments (mouse skin wound infection and Galleria mellonella infection models) confirmed that Ru-6 effectively eradicates MRSA without significant toxicity to host tissues. Ru-6 exhibits considerable potential as a novel antimicrobial agent for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, China.
- School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, China. Electronic address: xiongys1214@163.com.
Förderung
- Jiangxi Science and Technology Normal University
- Jiangxi Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Wang, W. P., Deng, W., Wang, J. T., Liao, X. W., Yu, R. J., & Xiong, Y. S. (2026). Ruthenium complexes as potent antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) via membrane damage. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110463
Vancouver
Wang WP, Deng W, Wang JT, Liao XW, Yu RJ, Xiong YS. Ruthenium complexes as potent antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) via membrane damage. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110463
BibTeX
@article{Wang2026,
author = {Wang, Wen-Ping and Deng, Wei and Wang, Jin-Tao and Liao, Xiang-Wen and Yu, Ru-Jian and Xiong, Yan-Shi},
title = {Ruthenium complexes as potent antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) via membrane damage},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110463}
}
EUVIMED